0 CHECKOUT

Kazakhstan Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3517975
  • December 2015
  • Region: Kazakhstan
  • 76 pages
  • Business Monitor International
1 of 4

Kazakhstan's pharmaceutical market will continue to grow at a rapid pace over our forecast period. Its accession into the Eurasian Economic Union (EAEU) will lead to access to better quality drugs at lower prices, increasing consumption as the country forms and integrates a common market for pharmaceuticals. Government expenditure on health continues to play a key role in boosting medicine consumption. However, unless the government steps up economic diversification and decreases its reliance on the oil sector, we doubt it will be able to sustain its current level of spending over the long-term.

Headline Expenditure Projections
- Pharmaceuticals: KZT310.05bn (USD1.73bn) in 2014 to KZT349.57bn (USD1.61bn) in 2015; +12.7%
in local currency terms and -6.6% in US dollar terms. Forecast in line with last quarter.

- Healthcare: KZT1.76trn (USD9.78bn) in 2014 to KZT2.05trn (USD9.45bn) in 2015; +16.6% in local currency terms and -3.4% in US dollar terms. Forecast in line with last quarter.

Note: Product cover images may vary from those shown
2 of 4

Table: Headline Pharmaceuticals & Healthcare Forecasts (Kazakhstan 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kazakhstan 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2011-2019)

Prescription Drug Market
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kazakhstan 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Kazakhstan 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Kazakhstan 2013-2019)

Industry Risk Reward Index

Central And Eastern Europe Risk/Reward Index - Q1 2016

Kazakhstan Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues

Pricing And Reimbursement Regime

Market Overview

Healthcare Sector

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Table: Multinational Market Activity

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

Chimpharm

Romat

Demographic Forecast

Demographic Outlook
Table: Population Headline Indicators (Kazakhstan 1990-2025)
Table: Key Population Ratios (Kazakhstan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Kazakhstan 1990-2025)
Table: Population By Age Group (Kazakhstan 1990-2025)
Table: Population By Age Group % (Kazakhstan 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Chimpharm
Romat

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.